NCT04925986 2025-04-17
Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC
Yale University
Phase 2 Terminated
Yale University
Fundación GECP
University of New Mexico
H. Lee Moffitt Cancer Center and Research Institute
The Methodist Hospital Research Institute
M.D. Anderson Cancer Center
Weill Medical College of Cornell University